Catheter Precision (VTAK) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
13 Mar, 2026Executive summary
Special Meeting scheduled for April 15, 2026, to vote on six key proposals impacting capital structure and governance.
Proposals include authorizations for new share issuances, a reverse stock split, and potential adjournment to solicit additional votes.
Board recommends voting in favor of all proposals to support financing, acquisitions, and compliance with NYSE American rules.
Forward-looking statements highlight risks if proposals are not approved, including financing challenges and potential dilution.
Voting matters and shareholder proposals
Proposal 1: Approve issuance of shares underlying Series C Preferred Stock, potentially exceeding 19.99% of outstanding shares.
Proposal 2: Approve issuance of shares underlying Series D Preferred Stock for FLYTE and Ponderosa Air acquisitions.
Proposal 3: Approve issuance of shares underlying Series J Preferred Stock, converting royalty rights held by insiders.
Proposal 4: Approve additional shares due to reduced conversion price of Series B Preferred Stock.
Proposal 5: Approve a reverse stock split at a ratio between 1-for-2 and 1-for-100, at Board discretion.
Proposal 6: Approve adjournment or postponement of the meeting to solicit more votes if needed.
Board of directors and corporate governance
Board unanimously recommends voting “FOR” all proposals.
Independent directors approved insider-related transactions, with interested parties abstaining.
Board retains discretion on timing and ratio of reverse stock split.
Latest events from Catheter Precision
- Registering up to $20M in securities, with proceeds for operations and growth in cardiac EP tech.VTAK
Registration Filing16 Dec 2025 - Registering 12.86M shares for resale by PIPE investors; proceeds only from warrant exercises.VTAK
Registration Filing16 Dec 2025 - Annual meeting to vote on director, share issuances, reverse split, and auditor ratification.VTAK
Proxy Filing1 Dec 2025 - Annual meeting seeks approval for director, share issuances, reverse split, and auditor ratification.VTAK
Proxy Filing1 Dec 2025 - Special Meeting seeks approval for key capital, equity, and governance proposals.VTAK
Proxy Filing1 Dec 2025 - Special Meeting to vote on warrant exercises, share increase, equity plan, and auditor ratification.VTAK
Proxy Filing1 Dec 2025 - Vote sought on major share authorization increase and auditor ratification to support future financing.VTAK
Proxy Filing1 Dec 2025 - Virtual annual meeting to vote on director, share issuances, reverse split, and auditor.VTAK
Proxy Filing1 Dec 2025 - New CFO appointed with significant stock options; two products begin revenue cycle.VTAK
Proxy Filing1 Dec 2025